What did @rob_kandels actually say?
Pretty brief, honestly. Rob is 26 years old and sharing his testosterone lab results while on TRT. He reports a total testosterone of 897 ng/dL and a free testosterone of 25, though he doesn't specify the unit for that free T number. He invites viewers to weigh in with their thoughts. That's the whole video. No dose disclosed, no reason for starting TRT, no context about where he was before treatment.
The lack of context is worth flagging right away. We don't know his pre-treatment baseline, his injection frequency, his ester type, or what symptoms prompted him to start TRT at 26. Those details matter enormously when evaluating whether these numbers are appropriate, conservative, or aggressive for his age.
Does the science back this up?
The numbers he's sharing are within the range most clinicians would consider acceptable for a man on TRT, but "acceptable" doesn't mean optimal or risk-free, especially at 26.
According to the American Urological Association (AUA) 2018 guidelines, a total testosterone of 897 ng/dL sits comfortably in the mid-to-high normal adult male reference range, which most major labs peg at roughly 300 to 1000 ng/dL. The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal levels, generally 400 to 700 ng/dL, for most hypogonadal patients. At 897, Rob is on the higher end of that spectrum but not wildly outside it.
Free testosterone at 25 is harder to interpret without the unit. If that's 25 pg/mL, it's elevated but not alarming. If it's 25 ng/dL, that's a different story entirely. This ambiguity is a real problem with how lab results get shared on social media.
What did they get wrong (or right)?
Rob gets credit for one thing: sharing actual lab numbers rather than just vibes. Most TRT content on TikTok is anecdote soup, so seeing a real result is at least a starting point for a real conversation.
What he got wrong, or at least incomplete, is the framing. A total T of 897 on TRT at age 26 raises some legitimate clinical questions he doesn't address. First, why TRT at 26? The Endocrine Society guidelines emphasize that TRT in younger men requires careful evaluation because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, which can impair fertility and, in younger men, may affect long-term testicular function (Ramasamy et al., 2014, Fertility and Sterility). Second, he provides no hematocrit or estradiol data, both of which are standard monitoring parameters under any responsible TRT protocol. Elevated hematocrit is one of the most common adverse effects of testosterone therapy and a real cardiovascular risk factor (Calof et al., 2005, Journals of Gerontology).
Presenting half a lab panel as "results" is misleading by omission, even if unintentionally.
What should you actually know?
If you're a young man watching this video and thinking about TRT, here's what the research actually says: TRT is an FDA-approved treatment for hypogonadism, defined clinically as consistently low testosterone paired with symptoms. It is not a general performance optimization tool, and starting it at 26 without a confirmed diagnosis carries real tradeoffs.
Fertility suppression is not a minor side effect. A study by Ramasamy et al. (2014, Fertility and Sterility) found that exogenous testosterone can significantly reduce sperm production, and while this is sometimes reversible, recovery is not guaranteed, particularly with prolonged use. Men who want biological children should have a serious conversation with a urologist or reproductive endocrinologist before starting TRT.
Beyond fertility, any responsible TRT protocol involves monitoring beyond just total and free testosterone. That includes estradiol, hematocrit, PSA (even in younger men at baseline), and lipid panels. Rob sharing two numbers without this context doesn't give anyone enough information to evaluate whether his protocol is being managed responsibly.
If you have genuine symptoms of low testosterone, including fatigue, low libido, depression, and reduced muscle mass, get tested through a legitimate clinical pathway, not a social media recommendation. A confirmed diagnosis, proper baseline labs, and ongoing monitoring are what separate legitimate TRT from hormone experimentation.